Company intelligence / Profile preview

Eurofins Discovery

Saint Charles, Missouri, United Stateseurofinsdiscovery.com ↗

Ownership: Private
Employees: ~667
Development stage: Commercial

Overview

Eurofins Discovery does not develop its own drugs or report clinical results. It provides contract research services—including medicinal chemistry, synthetic chemistry, in vitro pharmacology, in vivo studies via partners, ADME & toxicology—to pharma/biotech clients worldwide. Their products include qualified reagents/cell lines/assays to accelerate client R&D pipelines.

Therapeutic areas: Multiple
Modalities: Small moleculeBiologicPeptidesEnzymeCell line-based assays
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Eurofins Discovery.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eurofins Discovery.

Explore the full profile